mitoKATP channel activation in the postanoxic developing heart protects E-C coupling via NO-, ROS-, and PKC-dependent pathways.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 15550517)

Published in Am J Physiol Heart Circ Physiol on November 18, 2004

Authors

Alexandre Sarre1, Norbert Lange, Pavel Kucera, Eric Raddatz

Author Affiliations

1: Dept. of Physiology, Faculty of Biology and Medicine, University of Lausanne, 7 rue du Bugnon, 1005 Lausanne, Switzerland.

Articles by these authors

On the selectivity of 5-aminolevulinic acid-induced protoporphyrin IX formation. Curr Med Chem Anticancer Agents (2004) 1.65

Functional and morphological evidence for a ventricular conduction system in zebrafish and Xenopus hearts. Am J Physiol Heart Circ Physiol (2003) 1.54

A key role of TRPC channels in the regulation of electromechanical activity of the developing heart. Cardiovasc Res (2011) 1.54

Arrhythmogenesis in the developing heart during anoxia-reoxygenation and hypothermia-rewarming: an in vitro model. J Cardiovasc Electrophysiol (2006) 1.48

Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer--a multicenter study. J Urol (2003) 1.33

Bacteria capture iron from heme by keeping tetrapyrrol skeleton intact. Proc Natl Acad Sci U S A (2009) 1.27

The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systems. Adv Drug Deliv Rev (2007) 1.20

Stimulation of anti-tumor immunity by photodynamic therapy. Expert Rev Clin Immunol (2011) 1.11

Green tea extract and its major polyphenol (-)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy. Am J Physiol Cell Physiol (2006) 1.11

5-Aminolevulinic acid derivatives in photomedicine: Characteristics, application and perspectives. Photochem Photobiol (2007) 1.07

Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters. Adv Drug Deliv Rev (2004) 1.02

Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer. Int J Pharm (2006) 0.96

Effects on gram-negative and gram-positive bacteria mediated by 5-aminolevulinic Acid and 5-aminolevulinic acid derivatives. Antimicrob Agents Chemother (2008) 0.95

Inhibition of serotonergic medullary raphe obscurus neurons suppresses genioglossus and diaphragm activities in anesthetized but not conscious rats. J Appl Physiol (1985) (2006) 0.95

STAT3α interacts with nuclear GSK3beta and cytoplasmic RISK pathway and stabilizes rhythm in the anoxic-reoxygenated embryonic heart. Basic Res Cardiol (2011) 0.90

Simultaneous but not prior inhibition of VEGF165 enhances the efficacy of photodynamic therapy in multiple models of ocular neovascularization. Invest Ophthalmol Vis Sci (2008) 0.90

Like a bolt from the blue: phthalocyanines in biomedical optics. Molecules (2011) 0.89

Synergies of VEGF inhibition and photodynamic therapy in the treatment of age-related macular degeneration. Invest Ophthalmol Vis Sci (2007) 0.88

Production of reactive oxygen species from photosensitizers activated with visible light sources available in dental offices. Photomed Laser Surg (2010) 0.87

Blue light-mediated inactivation of Enterococcus faecalis in vitro. Photodiagnosis Photodyn Ther (2012) 0.86

Myocardial impairment in chronic hypoxia is abolished by short aeration episodes: involvement of K+ATP channels. Exp Biol Med (Maywood) (2004) 0.84

Activation of transient receptor potential canonical 3 (TRPC3)-mediated Ca2+ entry by A1 adenosine receptor in cardiomyocytes disturbs atrioventricular conduction. J Biol Chem (2012) 0.84

Polymeric photosensitizer prodrugs for photodynamic therapy. Photochem Photobiol (2007) 0.84

Developmental changes in cardiac recovery from anoxia-reoxygenation. Am J Physiol Regul Integr Comp Physiol (2002) 0.84

Improved photodynamic activity of porphyrin loaded into nanoparticles: an in vivo evaluation using chick embryos. Int J Pharm (2004) 0.83

5-ALA derivative-mediated photoinactivation of Propionibacterium acnes. J Dermatol Sci (2009) 0.82

Tailoring protease-sensitive photodynamic agents to specific disease-associated enzymes. Bioconjug Chem (2007) 0.82

Targeting GLP-1 receptors for repeated magnetic resonance imaging differentiates graded losses of pancreatic beta cells in mice. Diabetologia (2014) 0.82

Understanding gastric forces calculated from high-resolution pill tracking. Proc Natl Acad Sci U S A (2010) 0.81

Direct electrical stimulation using a battery-operated device for induction and modulation of colonic contractions in pigs. Ann Biomed Eng (2010) 0.80

Adenosine A1 receptor activation is arrhythmogenic in the developing heart through NADPH oxidase/ERK- and PLC/PKC-dependent mechanisms. J Mol Cell Cardiol (2011) 0.80

Quenching-induced deactivation of photosensitizer by nanoencapsulation to improve phototherapy of cancer. J Drug Target (2009) 0.80

Protoporphyrin (PPIX) efflux by the MacAB-TolC pump in Escherichia coli. Microbiologyopen (2014) 0.80

Specific inhibition of HCN channels slows rhythm differently in atria, ventricle and outflow tract and stabilizes conduction in the anoxic-reoxygenated embryonic heart model. Pharmacol Res (2009) 0.80

In vitro skin permeation and retention of 5-aminolevulinic acid ester derivatives for photodynamic therapy. J Control Release (2003) 0.79

Thrombin-sensitive dual fluorescence imaging and therapeutic agent for detection and treatment of synovial inflammation in murine rheumatoid arthritis. J Control Release (2012) 0.79

Comparison of ALA- and ALA hexyl-ester-induced PpIX depth distribution in human skin carcinoma. J Photochem Photobiol B (2008) 0.79

Transient anoxia and oxyradicals induce a region-specific activation of MAPKs in the embryonic heart. Mol Cell Biochem (2010) 0.78

Thermosetting gel for the delivery of 5-aminolevulinic acid esters to the cervix. J Pharm Sci (2008) 0.78

Thrombin-sensitive photodynamic agents: a novel strategy for selective synovectomy in rheumatoid arthritis. J Control Release (2009) 0.78

Enhanced prostate cancer targeting by modified protease sensitive photosensitizer prodrugs. Mol Pharm (2012) 0.78

Enhanced delivery of 5-aminolevulinic acid esters by iontophoresis in vitro. Photochem Photobiol (2003) 0.77

Involvement of CD73, equilibrative nucleoside transporters and inosine in rhythm and conduction disturbances mediated by adenosine A1 and A2A receptors in the developing heart. J Mol Cell Cardiol (2013) 0.77

Local electrogram delay recorded from left ventricular lead at implant predicts response to cardiac resynchronization therapy: retrospective study with 1 year follow up. BMC Cardiovasc Disord (2012) 0.77

Selective photodetection and photodynamic therapy for prostate cancer through targeting of proteolytic activity. Mol Cancer Ther (2012) 0.77

Protoporphyrin IX photodynamic therapy for synovitis. Arthritis Rheum (2002) 0.77

The L-Type Ca+ and KATP channels may contribute to pacing-induced protection against anoxia-reoxygenation in the embryonic heart model. J Cardiovasc Electrophysiol (2008) 0.77

On the cutting edge: protease-sensitive prodrugs for the delivery of photoactive compounds. Photochem Photobiol Sci (2011) 0.76

Fluorescence diagnosis using enzyme-related metabolic abnormalities of neoplasia. J Environ Pathol Toxicol Oncol (2006) 0.76

Intracellular reactive oxygen species in monocytes generated by photosensitive chromophores activated with blue light. Dent Mater (2008) 0.76

Benefits of nanoencapsulation for the hypercin-mediated photodetection of ovarian micrometastases. Eur J Pharm Biopharm (2008) 0.76

Toward the understanding of the photodynamic activity of m-THPP encapsulated in PLGA nanoparticles: correlation between nanoparticle properties and in vivo activity. J Drug Target (2009) 0.75

Analysis of differential PDT effect in rat bladder tumor models according to concentrations of intravesical hexyl-aminolevulinate. Photochem Photobiol Sci (2008) 0.75

Hexyl-aminolevulinate-mediated photodynamic therapy: how to spare normal urothelium. An in vitro approach. Lasers Surg Med (2007) 0.75

Kondrat'eva ligation: Diels-Alder-based irreversible reaction for bioconjugation. J Org Chem (2014) 0.75

Ventricular but not atrial electro-mechanical delay of the embryonic heart is altered by anoxia-reoxygenation and improved by nitric oxide. Mol Cell Biochem (2004) 0.75

Screening of nanoparticulate delivery systems for the photodetection of cancer in a simple and cost-effective model. Nanomedicine (Lond) (2009) 0.75

In vitro metabolism of 5-ALA esters derivatives in hairless mice skin homogenate and in vivo PpIX accumulation studies. Pharm Res (2004) 0.75

Noninvasive verification of nasogastric tube placement using a magnet-tracking system: a pilot study in healthy subjects. JPEN J Parenter Enteral Nutr (2005) 0.75

Pharmaceutical technology at the service of targeted drug delivery. Chimia (Aarau) (2012) 0.75

Modulation of the c-Jun N-terminal kinase activity in the embryonic heart in response to anoxia-reoxygenation: involvement of the Ca2+ and mitoKATP channels. Mol Cell Biochem (2008) 0.75